scholarly journals Ketogenic diet (KD) therapy in the acute phase of febrile infection-related epilepsy syndrome (FIRES): a case report

2021 ◽  
Vol 0 (0) ◽  
pp. 0-0
Author(s):  
Wen-Jing Li ◽  
Chun-Ling Xue ◽  
Yong Zhang ◽  
Li-Hui Wu ◽  
Dong-Mei Chen ◽  
...  
Keyword(s):  
Case Report ◽  
Ketogenic Diet ◽  
Acute Phase ◽  
Epilepsy Syndrome

A novel case report of severe hypercalcaemia occurring after four years on the ketogenic diet

2019 ◽  
Author(s):  
Jessica Sandy ◽  
Alessandra Cocca ◽  
Moira Cheung ◽  
Daniel Lumsden ◽  
Sophia Sakka
Keyword(s):  
Case Report ◽  
Ketogenic Diet ◽  
Severe Hypercalcaemia

scholarly journals Cognitive–Evaluative Dimension of Pain in Neuropathic Pain Relapse in Sciatica: A Case Report

Medicina ◽  
2021 ◽  
Vol 57 (7) ◽  
pp. 658
Author(s):  
Tsubasa Kawasaki ◽  
Takuya Yada ◽  
Masahiro Ohira
Keyword(s):  
Neuropathic Pain ◽  
Low Back Pain ◽  
Back Pain ◽  
Case Report ◽  
Acute Phase ◽  
Low Back ◽  
Evaluative Dimension ◽  
Long Duration ◽  
Improvement Process ◽  
Insight Into

The cognitive–evaluative (C–E) dimension of pain is commonly observed in patients with a relatively long duration of pain. However, little is known about the effects of pain relapse on the C–E dimension of pain. Moreover, the improvement process of the C–E dimension of pain following treatment is unknown. The objective of this case report was to (a) demonstrate that the C–E dimension was affected in the acute phase of neuropathic pain in cases of pain relapse, and (b) demonstrate the improvement process of the C–E dimension of pain. A woman was diagnosed with low back pain (LBP) and sciatica. The patient had previously experienced symptoms of LBP and sciatica; thus, this episode was a case of pain relapse. At the beginning of rehabilitation, the C–E dimension of pain was present in addition to the sensory–discriminative (S–D) dimension of pain. It was observed that improvement of the C–E dimension of pain was delayed in comparison with that of the S–D dimension of pain. The C–E dimension of pain was observed with pain relapse even though it was in the acute phase of pain. This case provides a novel insight into the C–E dimension of pain. Moreover, the delay in improving the C–E dimension of pain indicates a difference in the improvement process for each pain dimension.

Possible Role of High-Dose Barbiturates and Early Administration of Parenteral Ketogenic Diet for Reducing Development of Chronic Epilepsy in Febrile Infection-Related Epilepsy Syndrome: A Case Report

2020 ◽  
Author(s):  
Shimpei Baba ◽  
Tohru Okanishi ◽  
Koichi Ohsugi ◽  
Rika Suzumura ◽  
Keiko Niimi ◽  
...  
Keyword(s):  
Continuous Infusion ◽  
Ketogenic Diet ◽  
Epilepsy Syndrome ◽  
High Dose ◽  
Early Administration ◽  
Chronic Epilepsy ◽  
Time Period ◽  
Irreversible Brain Damage ◽  
Electroencephalogram Eeg

AbstractWe describe the efficacy of high-dose barbiturates and early administration of a parenteral ketogenic diet (KD) as initial treatments for acute status epilepticus (SE) in an 8-year-old girl with febrile infection-related epilepsy syndrome (FIRES). The patient was admitted to our hospital with refractory focal SE. Abundant epileptic discharges over the left frontal region were observed on electroencephalogram (EEG). Treatment with continuous infusion of thiamylal for 4 hours, increased incrementally to 40 mg/kg/h, successfully ended the clinical SE, and induced a burst-suppression coma. The infusion rate was then gradually decreased to 4 mg/kg/h over the next 12 hours. Parenteral KD was administered from days 6 to 21 of illness. Continuous infusion of thiamylal was switched to midazolam on day 10 without causing seizures or EEG exacerbations. The patient has remained seizure free in the 15 months since hospital discharge. The effectiveness of KD for the treatment of FIRES has attracted attention amongst clinicians, but KD treatment may need to last for 2 to 4 days before it can stop SE, a time period that could cause irreversible brain damage. Considering the severity of SE in our patient and the dose of barbiturates needed to treat it, we consider this case to have had a good clinical outcome. The results suggest that rapid termination of seizure using high-dose barbiturates in conjunction with early administration of parenteral KD could reduce the development of chronic epilepsy in patients with FIRES.

Choice of pharmaceutical form as a key factor during ketogenic diet: a case report

2021 ◽  
pp. ejhpharm-2021-002727
Author(s):  
Héctor Rodríguez-Ramallo ◽  
Nerea Báez-Gutiérrez ◽  
Justo Valverde Fernandez ◽  
Francisco José Araujo-Rodríguez
Keyword(s):  
Case Report ◽  
Ketogenic Diet ◽  
Key Factor ◽  
Pharmaceutical Form

scholarly journals Ketogenic Diet as a Trigger for Diabetic Ketoacidosis in a Misdiagnosis of Diabetes: A Case Report

2020 ◽  
Vol 38 (3) ◽  
pp. 318-321
Author(s):  
Alexander J. White-Cotsmire ◽  
Amber M. Healy
Keyword(s):  
Case Report ◽  
Diabetic Ketoacidosis ◽  
Ketogenic Diet

scholarly journals The use of the ketogenic diet in the treatment of epileptic encephalopathies

2018 ◽  
Author(s):  
Roberto Caraballo
Keyword(s):  
Ketogenic Diet ◽  
Case Reports ◽  
Case Series ◽  
Dravet Syndrome ◽  
Epilepsy Syndrome ◽  
Behavioral Disturbances ◽  
Paroxysmal Activity ◽  
Epileptic Encephalopathies ◽  
Progressive Encephalopathy ◽  
Epileptic Syndromes

Epileptic encephalopathies(EE) are severe conditions characterized by paroxysmal activity on the electroencephalogram (EEG) that is often aggressive, seizures that are commonly multi-form and intractable, and severe cognitive and behavioral disturbances that present or worsen after the onset of epilepsy. The ketogenic diet (KD) has been shown to be effective in the treatment of refractory epileptic encephalopathies, and has been suggested as an early treatment option in very young children. Although the experience is often anecdotal and mostly consists of case reports and case series, the aim of this study was to present our own experience and an overview of the current literature on the diet in patients with EE. Some encephalopathies, such as epilepsy with myoclonic and atonic seizures, West syndrome, Dravet syndrome, or Lennox-Gastaut syndrome, are well recognized and known to have a good response to the ketogenic diet, while others are more rare or only recently identified, such as epilepsy with focal migrating seizures in infancy, febrile infection-related epilepsy syndrome, or myclonic status in non-progressive encephalopathy, about which little is known and the KD is only tried in sporadic cases. EE are typically refractory to the antiepileptic drugs and the KD  should be considered earlier in the therapeutic scheme of these severe epileptic syndromes. The KD including the oral formula may be considered in all pediatric patients with EE even in infancy.

scholarly journals Actinic cheilitis: a case report and a review of the literature

2016 ◽  
Vol 31 (1) ◽  
pp. 45
Author(s):  
Dasaiev M. Dutra ◽  
Maria Auxiliadora G do Nascimento ◽  
Maria Sueli Marques Soares
Keyword(s):  
Case Report ◽  
Triamcinolone Acetonide ◽  
Acute Phase ◽  
Inflammatory Process ◽  
Premalignant Lesions ◽  
Review Of The Literature ◽  
Actinic Cheilitis ◽  
Anti Inflammatory ◽  
Term Maintenance

Objective: This article presents a case report of actinic cheilitis with an acute inflammatory process and need for anti- inflammatory treatment.Case Report: Triamcinolone acetonide in Orabase was prescribed 3 times a day for 15 days, and the patient was advised to use sunscreen and hats. After 7 days, there was a significant improvement in the acute phase and the patient was kept under observation.Conclusion: It is emphasized that it is important to intervene in the evolution of the inflammatory process in premalignant lesions in order to prevent its long-term maintenance.

Sign in / Sign up

Export Citation Format

Share Document